Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of tacrolimus in early post–heart and lung transplantation
2012-001909-24Phase 4Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Apr 2012
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tacrolimus in post-orthotopic heart transplantation status, sponsored by University Medical Center Utrecht. Primary endpoints: Tacrolimus whole blood and unbound plasma concentrations and Tacrolimus pharmacokinetic parameters. Started Apr 2012; status: completed.
02
Drugs
tacrolimus
03
Conditions
post-orthotopic heart transplantation status
Beyond the preview
Go deeper on 2012-001909-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001909-24.